Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Herpes Simplex/metabolism"'
Publikováno v:
Current opinion in virology. 2(1)
Herpes simplex virus (HSV) entry into the cell involves the fusion of the virion envelope with a cellular membrane and delivery of capsid and tegument proteins to the cytoplasm. Our understanding of this phenomenon has greatly increased in recent yea
Autor:
Sanchez-Quiles, V. (Virginia), Mora, M.I. (María I.), Segura, V. (Víctor), Greco, A. (Anna), Epstein, A.L. (Alberto L.), Foschini, M.G. (María Giovanna), Dayon, L. (Loïc), Sánchez, J.C. (Jean-Charles), Prieto, J. (Jesús), Corrales, F.J. (Fernando José), Santamaria, E. (Enrique)
Herpesvirus type 1 (HSV-1) based oncolytic vectors arise as a promising therapeutic alternative for neoplastic diseases including hepatocellular carcinoma. However, the mechanisms mediating the host cell response to such treatments are not completely
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1111::1f8515037a48c1c906f73eff5b299831
https://hdl.handle.net/10171/21552
https://hdl.handle.net/10171/21552
Publikováno v:
European Journal of Biochemistry, Vol. 194, No 1 (1990) pp. 287-91
Neomycin, an inhibitor of inositol phospholipid turnover, prevents Herpes-simplex-virus-type-1 (HSV-1)-induced stimulation of ribosomal protein S6 phosphorylation, but does not impair the S6 phosphorylation induced by serum. Long-term treatment with